Collegium Pharmaceutical (COLL) Assets Growth (3y) (2017 - 2026)
Collegium Pharmaceutical (COLL) Assets Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Collegium Pharmaceutical | 887.15 Mn | 737.84 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.72% |
| Mar 31, 2026 | 10.80% |
| Dec 31, 2025 | 12.16% |
| Sep 30, 2025 | 10.20% |
| Jun 30, 2025 | 8.54% |
| Mar 31, 2025 | 9.39% |
| Dec 31, 2024 | 33.96% |
| Sep 30, 2024 | 30.14% |
| Jun 30, 2024 | 13.85% |
| Mar 31, 2024 | 19.92% |
| Dec 31, 2023 | 21.10% |
| Sep 30, 2023 | 22.29% |
| Jun 30, 2023 | 23.35% |
| Mar 31, 2023 | 24.14% |
| Dec 31, 2022 | 56.50% |
| Sep 30, 2022 | 58.09% |
| Jun 30, 2022 | 60.44% |
| Mar 31, 2022 | 61.77% |
| Dec 31, 2021 | 33.44% |
| Sep 30, 2021 | 4.69% |